Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Lipase H (LIPH) is a membrane-bound enzyme of the mammalian triglyceride lipase family that hydrolyzes phosphatidic acid to generate lysophosphatidic acid (LPA), a potent lipid mediator involved in multiple cellular processes, including cell proliferation, migration, apoptosis, and the maturation of hair follicle cells. LIPH is crucial for normal development and maintenance of hair follicles and is predominantly expressed in hair follicle cells, skin epidermis, and sebaceous glands. Mutations in the LIPH gene cause rare autosomal recessive conditions such as hypotrichosis and woolly hair, characterized by abnormal hair texture, sparsity, and increased fragility, linked to impaired LPA production and defective hair follicle function. Currently, LIPH is not known to be targeted by any approved drugs, and its main clinical relevance is as a diagnostic marker for genetic hair disorders rather than as a therapeutic target.
not applicable; no approved drugs target LIPH directly as a therapeutic mechanism
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Lipase H (LIPH).